Azenta Inc (AZTA) News

Form 8-K - Current report

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast PR...

Form 3 - Initial statement of beneficial ownership of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to...

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test PR Newswire BURLINGTON...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report